Adhesio interthalamica alterations in schizophrenia spectrum disorders: A systematic review and meta-analysis

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorTRZESNIAK, Clarissa
dc.contributor.authorKEMPTON, Matthew J.
dc.contributor.authorBUSATTO, Geraldo F.
dc.contributor.authorOLIVEIRA, Irismar Reis de
dc.contributor.authorALMEIDA, Amanda Galvao-de
dc.contributor.authorKAMBEITZ, Joseph
dc.contributor.authorFERRARI, Maria Cecilia Freitas
dc.contributor.authorSANTOS FILHO, Alaor
dc.contributor.authorCHAGAS, Marcos H. N.
dc.contributor.authorZUARDI, Antonio W.
dc.contributor.authorHALLAK, Jaime E. C.
dc.contributor.authorMCGUIRE, Phillip K.
dc.contributor.authorCRIPPA, Jose Alexandre S.
dc.date.accessioned2017-11-27T16:34:30Z
dc.date.available2017-11-27T16:34:30Z
dc.date.issued2011
dc.description.abstractMagnetic resonance imaging (MRI) studies have reported a variety of brain abnormalities in association with schizophrenia. These include a higher prevalence of an absent adhesio interthalamica (Al; also known massa intermedia), a gray matter junction that is present between the two thalami in approximately 80% of healthy subjects. In this meta-analytic review, we describe and discuss the main Al MRI findings in schizophrenia spectrum disorders (SSDs) to date. The MEDLINE and ISI Web of Knowledge(SM) databases were searched up to December 2010, for studies that used MRI to assess Al in patients with SSD and controls. From fourteen potential reports, eleven were eligible to be part of the current review. These studies included 822 patients with SSD and 718 healthy volunteers. There was a large degree of variability in the MRI methods they employed. Patients with SSD had a higher prevalence of absent Al than healthy volunteers (odds ratio = 1.98; 95% confidence interval 1.33-2.94: p=0.0008). This association was evident in both male and female SSD subjects, and there was no evidence that the prevalence was related to age or duration of illness. The significance of the absence of an Al for SSD may be clarified by studies in large, longitudinal community-based samples using standardized methods.
dc.description.indexMEDLINE
dc.description.sponsorshipCoordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-Brazil) [5797/09-8]
dc.description.sponsorshipConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-Brazil)
dc.description.sponsorshipFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP-Brazil)
dc.identifier.citationPROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, v.35, n.4, p.877-886, 2011
dc.identifier.doi10.1016/j.pnpbp.2010.12.024
dc.identifier.issn0278-5846
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/23399
dc.language.isoeng
dc.publisherPERGAMON-ELSEVIER SCIENCE LTD
dc.relation.ispartofProgress in Neuro-Psychopharmacology & Biological Psychiatry
dc.rightsrestrictedAccess
dc.rights.holderCopyright PERGAMON-ELSEVIER SCIENCE LTD
dc.subjectAdhesio interthalamica
dc.subjectMagnetic resonance imaging
dc.subjectMassa intermedia
dc.subjectMeta-analysis
dc.subjectSchizophrenia
dc.subjectThalamus
dc.subject.othermidline brain structures
dc.subject.othercavum septum pellucidum
dc.subject.othermassa-intermedia
dc.subject.otherdopaminergic pathways
dc.subject.otherpersonality-disorder
dc.subject.otherfunctional psychoses
dc.subject.otherantipsychotic-drugs
dc.subject.otherbipolar disorder
dc.subject.otherthalamic nuclei
dc.subject.othersex-differences
dc.subject.wosClinical Neurology
dc.subject.wosNeurosciences
dc.subject.wosPharmacology & Pharmacy
dc.subject.wosPsychiatry
dc.titleAdhesio interthalamica alterations in schizophrenia spectrum disorders: A systematic review and meta-analysis
dc.typearticle
dc.type.categoryreview
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.affiliation.countryInglaterra
hcfmusp.affiliation.countryisogb
hcfmusp.author.externalTRZESNIAK, Clarissa:USP, FMRP, Sch Med, Dept Neurosci & Behav Sci, BR-14048900 Ribeirao Preto, SP, Brazil; Kings Coll London, Inst Psychiat, Dept Psychosis, London, England
hcfmusp.author.externalKEMPTON, Matthew J.:Kings Coll London, Inst Psychiat, Dept Psychosis, London, England
hcfmusp.author.externalOLIVEIRA, Irismar Reis de:Univ Fed Bahia, Affect Disorders Ctr, Salvador, BA, Brazil
hcfmusp.author.externalALMEIDA, Amanda Galvao-de:Univ Fed Bahia, Affect Disorders Ctr, Salvador, BA, Brazil; Univ Fed Sao Paulo, Post Grad Program, Sao Paulo, Brazil; LiNC, Sao Paulo, Brazil
hcfmusp.author.externalKAMBEITZ, Joseph:Kings Coll London, Inst Psychiat, Dept Psychosis, London, England
hcfmusp.author.externalMCGUIRE, Phillip K.:Kings Coll London, Inst Psychiat, Dept Psychosis, London, England
hcfmusp.citation.scopus37
hcfmusp.contributor.author-fmusphcGERALDO BUSATTO FILHO
hcfmusp.description.beginpage877
hcfmusp.description.endpage886
hcfmusp.description.issue4
hcfmusp.description.volume35
hcfmusp.origemWOS
hcfmusp.origem.pubmed21300129
hcfmusp.origem.scopus2-s2.0-79956021243
hcfmusp.origem.wosWOS:000291848000009
hcfmusp.publisher.cityOXFORD
hcfmusp.publisher.countryENGLAND
hcfmusp.relation.referenceAgarwal N, 2008, J PSYCHIATR NEUROSCI, V33, P440
hcfmusp.relation.referenceALLEN LS, 1991, J COMP NEUROL, V312, P97, DOI 10.1002/cne.903120108
hcfmusp.relation.referenceAmerican Psychiatric Association, 1987, DIAGN STAT MAN MENT
hcfmusp.relation.referenceAmerican Psychiatric Association, 2000, DIAGN STAT MAN MENT
hcfmusp.relation.referenceAmerican Psychiatric Association, 1994, DIAGN STAT MAN MENT
hcfmusp.relation.referenceShenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3
hcfmusp.relation.referenceANDREASEN NC, 1994, SCIENCE, V266, P294, DOI 10.1126/science.7939669
hcfmusp.relation.referenceSPITZER RL, 1978, ARCH GEN PSYCHIAT, V35, P773
hcfmusp.relation.referenceKempton MJ, 2010, SCHIZOPHR RES, V120, P54, DOI 10.1016/j.schres.2010.03.036
hcfmusp.relation.referenceHIRAYASU Y, 1992, BRAIN RES, V577, P36, DOI 10.1016/0006-8993(92)90534-G
hcfmusp.relation.referenceHill C, 1996, AM J PSYCHIAT, V153, P533
hcfmusp.relation.referenceCrippa JAD, 2006, EUR PSYCHIAT, V21, P291, DOI 10.1016/j.eurpsy.2005.09.010
hcfmusp.relation.referenceSusser E, 1998, BIOL PSYCHIAT, V44, P141, DOI 10.1016/S0006-3223(97)00427-7
hcfmusp.relation.referenceTakahashi T, 2008, PROG NEURO-PSYCHOPH, V32, P1708, DOI 10.1016/j.pnpbp.2008.07.007
hcfmusp.relation.referenceBrown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361
hcfmusp.relation.referenceChakos MH, 2005, BRIT J PSYCHIAT, V186, P26, DOI 10.1192/bjp.186.1.26
hcfmusp.relation.referenceTakahashi T, 2008, PSYCHIAT RES-NEUROIM, V162, P101, DOI 10.1016/j.pscychresns.2007.04.005
hcfmusp.relation.referenceHuedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193
hcfmusp.relation.referenceJakobsen KD, 2006, PSYCHOPATHOLOGY, V39, P269, DOI 10.1159/000095731
hcfmusp.relation.referenceHiggins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
hcfmusp.relation.referenceWRIGHT P, 1995, AM J PSYCHIAT, V152, P1714
hcfmusp.relation.referenceTakahashi T, 2009, PROG NEURO-PSYCHOPH, V33, P1058, DOI 10.1016/j.pnpbp.2009.05.020
hcfmusp.relation.referenceTomelleri L, 2009, EUR NEUROPSYCHOPHARM, V19, P835, DOI 10.1016/j.euroneuro.2009.07.007
hcfmusp.relation.referenceNaylor CD, 1997, BRIT MED J, V315, P617
hcfmusp.relation.referencePantelis C, 2005, SCHIZOPHRENIA BULL, V31, P672, DOI 10.1093/schbul/sbi034
hcfmusp.relation.referenceTakahashi T, 2010, J AFFECT DISORDERS, V122, P301, DOI 10.1016/j.jad.2009.09.003
hcfmusp.relation.referenceROSALES RK, 1968, J NEUROPATH EXP NEUR, V27, P166
hcfmusp.relation.referenceTakahashi T, 2008, PSYCHIAT RES-NEUROIM, V164, P90, DOI 10.1016/j.pscychresns.2008.03.001
hcfmusp.relation.referenceEgger M, 1997, BRIT MED J, V315, P629
hcfmusp.relation.referenceKwon JS, 1998, AM J PSYCHIAT, V155, P509
hcfmusp.relation.referenceShimizu M, 2008, SCHIZOPHR RES, V101, P331, DOI 10.1016/j.schres.2007.12.486
hcfmusp.relation.referenceEllison-Wright I, 2008, AM J PSYCHIAT, V165, P1015, DOI 10.1176/appi.ajp.2008.07101562
hcfmusp.relation.referenceTrzesniak C, 2011, SCHIZOPHR RES, V125, P1, DOI 10.1016/j.schres.2010.09.016
hcfmusp.relation.referenceCohen BM, 1998, PSYCHOPHARMACOLOGY, V135, P37, DOI 10.1007/s002130050483
hcfmusp.relation.referenceSAMRA KA, 1968, RADIOLOGY, V91, P1124
hcfmusp.relation.referenceMCGLONE J, 1980, BEHAV BRAIN SCI, V3, P215
hcfmusp.relation.referenceWOUTERLOOD FG, 1990, J COMP NEUROL, V296, P179, DOI 10.1002/cne.902960202
hcfmusp.relation.referenceKasai K, 2004, SCHIZOPHR RES, V71, P65, DOI 10.1016/j.schres.2003.12.010
hcfmusp.relation.referenceCeyhan M, 2008, ACTA NEUROPSYCHIATR, V20, P193, DOI 10.1111/j.1601-5215.2008.00296.x
hcfmusp.relation.referenceCheniaux E, 2009, PSYCHOPATHOLOGY, V42, P293, DOI 10.1159/000228838
hcfmusp.relation.referenceCHERAMY A, 1984, NEUROSCI LETT, V44, P193, DOI 10.1016/0304-3940(84)90080-6
hcfmusp.relation.referenceCohen BM, 1996, AM J PSYCHIAT, V153, P104
hcfmusp.relation.referenceErbagci H, 2002, SCHIZOPHR RES, V55, P89, DOI 10.1016/S0920-9964(01)00199-2
hcfmusp.relation.referenceEttinger U, 2007, ARCH GEN PSYCHIAT, V64, P401, DOI 10.1001/archpsyc.64.4.401
hcfmusp.relation.referenceHallak JEC, 2007, ARQ NEURO-PSIQUIAT, V65, P1216, DOI 10.1590/S0004-282X2007000700024
hcfmusp.relation.referenceJager M, 2004, PSYCHOPATHOLOGY, V37, P110, DOI 10.1159/000078609
hcfmusp.relation.referenceKuloglu M, 2008, PROG NEURO-PSYCHOPH, V32, P1353, DOI 10.1016/j.pnpbp.2008.04.014
hcfmusp.relation.referenceLEVIEL V, 1981, BRAIN RES, V223, P257, DOI 10.1016/0006-8993(81)91140-9
hcfmusp.relation.referenceMalobabić S, 1987, Gegenbaurs Morphol Jahrb, V133, P175
hcfmusp.relation.referenceMeisenzahl EM, 2002, PSYCHIAT RES-NEUROIM, V115, P127, DOI 10.1016/S0925-4927(02)00044-6
hcfmusp.relation.referenceMeisenzahl EM, 2000, AM J PSYCHIAT, V157, P823, DOI 10.1176/appi.ajp.157.5.823
hcfmusp.relation.referenceMURRAY RM, 1987, BRIT MED J, V295, P681
hcfmusp.relation.referenceNopoulos PC, 2001, SCHIZOPHR RES, V48, P177, DOI 10.1016/S0920-9964(00)00067-0
hcfmusp.relation.referenceROMO R, 1984, BRAIN RES, V308, P43, DOI 10.1016/0006-8993(84)90915-6
hcfmusp.relation.referenceSharp S, 1998, STATA TECH B, V42, P16, DOI 10.1002/SIM.1187/FULL)
hcfmusp.relation.referenceSnyder PJ, 1998, J NEUROIMAGING, V8, P159
hcfmusp.relation.referenceSTONE JM, 2010, PSYCHIAT RES, V30, P174
hcfmusp.relation.referenceSTONE JM, 2009, BIOL PSYCHIAT, V15, P533
hcfmusp.relation.referenceSutton A.J., 2000, METHODS METAANALYSIS
hcfmusp.relation.referenceTakahashi T, 2008, PROG NEURO-PSYCHOPH, V32, P1236, DOI 10.1016/j.pnpbp.2008.03.014
hcfmusp.relation.referenceTakahashi T, 2009, PROG NEURO-PSYCHOPH, V33, P842, DOI 10.1016/j.pnpbp.2009.03.035
hcfmusp.relation.referenceToda Mitsuru, 2007, Curr Psychiatry Rep, V9, P329, DOI 10.1007/s11920-007-0041-7
hcfmusp.relation.referenceWEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660
hcfmusp.relation.referenceWilson Christina, 2010, Clin Schizophr Relat Psychoses, V4, P124, DOI 10.3371/CSRP.4.2.4
hcfmusp.scopus.lastupdate2024-04-12
relation.isAuthorOfPublicationf6a44968-6960-4bd5-8722-8f605420e6bd
relation.isAuthorOfPublication.latestForDiscoveryf6a44968-6960-4bd5-8722-8f605420e6bd
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_TRZESNIAK_Adhesio_interthalamica_alterations_in_schizophrenia_spectrum_disorders_A_2011.PDF
Tamanho:
580.78 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)
Baixar
Coleções
Artigos e Materiais de Revistas Científicas - FM/MPS
Artigos e Materiais de Revistas Científicas - LIM/21